Literature DB >> 24603423

Comment on 'Acute thyroid eye disease (TED): principles of medical and surgical management'.

A S Litwin1, R Malhotra1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24603423      PMCID： PMC4017098          DOI： 10.1038/eye.2013.292

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  4 in total

Review 1.  Acute thyroid eye disease (TED): principles of medical and surgical management.

Authors:  D H Verity; G E Rose
Journal:  Eye (Lond)       Date:  2013-02-15       Impact factor: 3.775

2.  Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection.

Authors:  Jimmy M Uddin; Peter D Davies
Journal:  Ophthalmology       Date:  2002-06       Impact factor: 12.079

3.  A single transcutaneous injection with Botox for dysthyroid lid retraction.

Authors:  M-J Shih; S-L Liao; H-Y Lu
Journal:  Eye (Lond)       Date:  2004-05       Impact factor: 3.775

4.  Botulinum toxin type a for dysthyroid upper eyelid retraction.

Authors:  K E Morgenstern; J Evanchan; J A Foster; K V Cahill; J A Burns; D E E Holck; J D Perry; A E Wulc
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-05       Impact factor: 1.746
  4 in total
  1 in total

1.  Response to Drs Litwin and Malhotra.

Authors:  D H Verity; G E Rose
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.